Bausch Health Companies (BHC) Selling, General & Administrative (2009 - 2026)
Powered by 
Analysis
Bausch Health Companies (BHC) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 317.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 1.13 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 304.42 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 148.72 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 907.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -43.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 91.66 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 18.24 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 4.64 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 907.00 Mn |
| Mar 31, 2026 | 861.00 Mn |
| Dec 31, 2025 | 882.00 Mn |
| Sep 30, 2025 | 795.00 Mn |
| Jun 30, 2025 | 894.00 Mn |
| Mar 31, 2025 | 867.00 Mn |
| Dec 31, 2024 | 820.00 Mn |
| Sep 30, 2024 | 850.00 Mn |
| Jun 30, 2024 | 832.00 Mn |
| Mar 31, 2024 | 794.00 Mn |
| Dec 31, 2023 | 766.00 Mn |
| Sep 30, 2023 | 715.00 Mn |
| Jun 30, 2023 | 711.00 Mn |
| Mar 31, 2023 | 725.00 Mn |
| Dec 31, 2022 | 666.00 Mn |
| Sep 30, 2022 | 661.00 Mn |
| Jun 30, 2022 | 676.00 Mn |
| Mar 31, 2022 | 622.00 Mn |
| Dec 31, 2021 | 680.00 Mn |
| Sep 30, 2021 | 653.00 Mn |